• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未进行过相关研究的非洲镰状细胞贫血儿童群体的经颅多普勒超声速度

Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemia.

作者信息

O'Brien Nicole F, Moons Peter, Johnson Hunter, Tshimanga Taty, Musungufu Davin Ambitapio, Ekandji Robert Tandjeka, Mbaka Jean Pongo, Babatila Lydia Kuseyila, Mayindombe Ludovic, Giresse Buba, Mwanza Suzanna, Lupumpaula Clement, Chilima Janet Simanguwa, Nanyangwe Alice, Kabemba Peter, Kafula Lisa Nkole, Phiri Tusekile, June Sylvester, Gushu Montfort Bernard, Chagaluka George, Chunda-Liyoka Catherine M

机构信息

Department of Pediatrics Division of Critical Care Medicine Nationwide Children's Hospital, The Ohio State University Columbus Ohio USA.

Department of Pediatrics and Child Health Kamuzu University of Health Sciences Blantyre Malawi.

出版信息

EJHaem. 2023 Nov 29;5(1):3-10. doi: 10.1002/jha2.818. eCollection 2024 Feb.

DOI:10.1002/jha2.818
PMID:38406536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10887331/
Abstract

The greatest burden of sickle cell anemia (SCA) globally occurs in sub-Saharan Africa, where significant morbidity and mortality occur secondary to SCA-induced vasculopathy and stroke. Transcranial Doppler ultrasound (TCD) can grade the severity of vasculopathy, with disease modifying therapy resulting in stroke reduction in high-risk children. However, TCD utilization for vasculopathy detection in African children with SCA remains understudied. The objective was to perform a prospective, observational study of TCD findings in a cohort of children with SCA from the Democratic Republic of the Congo, Zambia, and Malawi. A total of 770 children aged 2-17 years without prior stroke underwent screening TCD. A study was scored as low risk when the time-averaged maximum of the mean (TAMMX) in the middle cerebral artery or terminal internal carotid artery was <170 cm/s but >50 cm/s, conditional risk when 170-200 cm/s, and high risk when >200 cm/s. Low-risk studies were identified in 604 children (78%), conditional risk in 129 children (17%), and high risk in three children (0.4%). Additionally, 34 (4%) were scored as having an unknown risk study (TAMMX <50 cm/s). Over the course of 15 months of follow-up, 17 children (2.2%) developed new neurologic symptoms (six with low-risk studies, seven with conditional risk, and four with unknown risk). African children with SCA in this cohort had a low rate of high-risk TCD screening results, even in those who developed new neurologic symptoms. Stroke in this population may be multifactorial with vasculopathy representing only one determinant. The development of a sensitive stroke prediction bundle incorporating relevant elements may help to guide preventative therapies in high-risk children.

摘要

镰状细胞贫血(SCA)在全球的最大负担出现在撒哈拉以南非洲地区,在那里,SCA引发的血管病变和中风导致了严重的发病率和死亡率。经颅多普勒超声(TCD)可以对血管病变的严重程度进行分级,疾病改善疗法可降低高危儿童中风的发生率。然而,TCD在非洲SCA儿童血管病变检测中的应用仍未得到充分研究。目的是对来自刚果民主共和国、赞比亚和马拉维的一组SCA儿童的TCD检查结果进行前瞻性观察研究。共有770名2至17岁且未曾中风的儿童接受了TCD筛查。当中脑动脉或颈内动脉终末段的平均时间平均最大流速(TAMMX)<170 cm/s但>50 cm/s时,研究被评为低风险;当TAMMX为170 - 200 cm/s时为条件风险;当TAMMX>200 cm/s时为高风险。604名儿童(78%)的研究被确定为低风险,129名儿童(17%)为条件风险,3名儿童(0.4%)为高风险。此外,34名儿童(4%)的研究被评为风险未知(TAMMX<50 cm/s)。在15个月的随访过程中,17名儿童(2.2%)出现了新的神经症状(6名低风险研究儿童、7名条件风险儿童和4名风险未知儿童)。该队列中的非洲SCA儿童高危TCD筛查结果的发生率较低,即使是那些出现新神经症状的儿童也是如此。该人群中的中风可能是多因素的,血管病变只是其中一个决定因素。开发一个包含相关要素的敏感中风预测组合可能有助于指导高危儿童的预防性治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb2/10887331/2610e285fb94/JHA2-5-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb2/10887331/2610e285fb94/JHA2-5-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcb2/10887331/2610e285fb94/JHA2-5-3-g001.jpg

相似文献

1
Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemia.未进行过相关研究的非洲镰状细胞贫血儿童群体的经颅多普勒超声速度
EJHaem. 2023 Nov 29;5(1):3-10. doi: 10.1002/jha2.818. eCollection 2024 Feb.
2
Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia.多米尼加共和国儿童中风预防(SACRED):镰状细胞贫血中风风险与羟基脲治疗的前瞻性研究方案
JMIR Res Protoc. 2017 Jun 2;6(6):e107. doi: 10.2196/resprot.7491.
3
Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.匹配同胞供者造血干细胞移植与镰状细胞贫血儿童经颅多普勒血流速度的相关性。
JAMA. 2019 Jan 22;321(3):266-276. doi: 10.1001/jama.2018.20059.
4
Can peak systolic velocities be used for prediction of stroke in sickle cell anemia?收缩期峰值速度能否用于预测镰状细胞贫血患者的中风?
Pediatr Radiol. 2005 Jan;35(1):66-72. doi: 10.1007/s00247-004-1282-9. Epub 2004 Oct 23.
5
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.扩大现有神经疾病的治疗范围(EXTEND):羟基脲治疗镰状细胞贫血的开放标签II期临床试验。
JMIR Res Protoc. 2016 Sep 12;5(3):e185. doi: 10.2196/resprot.5872.
6
Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.乌干达儿科镰状细胞贫血患者神经和神经认知功能障碍的负担(BRAIN SAFE):一项横断面研究。
BMC Pediatr. 2019 Oct 25;19(1):381. doi: 10.1186/s12887-019-1758-2.
7
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.羟基脲治疗可降低镰状细胞贫血伴高颅超声多普勒速度和脑血管病儿童的经颅超声多普勒速度,而无需输血支持:EXTEND 试验。
Br J Haematol. 2021 Nov;195(4):612-620. doi: 10.1111/bjh.17698. Epub 2021 Jul 22.
8
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.羟基脲加量用于坦桑尼亚镰状细胞贫血儿童一级卒中预防(SPHERE):一项开放标签、2 期试验。
Lancet Haematol. 2023 Apr;10(4):e261-e271. doi: 10.1016/S2352-3026(22)00405-7. Epub 2023 Mar 1.
9
Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.接受慢性输血以预防首发卒中的镰状细胞贫血儿童的经颅多普勒速度和脑 MRI/MRA 变化。
Pediatr Blood Cancer. 2013 Sep;60(9):1499-502. doi: 10.1002/pbc.24569. Epub 2013 Apr 26.
10
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.羟基脲与慢性输血用于维持镰状细胞贫血患儿经颅多普勒血流速度的比较——输血转换为羟基脲的经颅多普勒研究(TWiTCH):一项多中心、开放标签、3期、非劣效性试验。
Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.

引用本文的文献

1
Transcranial Doppler Screening in Sickle Cell Disease: Insights from a Regional Study in Karnataka, India.镰状细胞病的经颅多普勒筛查:来自印度卡纳塔克邦一项区域研究的见解
Ann Indian Acad Neurol. 2025 Jul 1;28(4):585-589. doi: 10.4103/aian.aian_65_25. Epub 2025 Jun 4.
2
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.在乌干达羟基脲试验中,尽管小儿镰状细胞贫血患者的经颅多普勒速度总体有所改善,但仍有卒中事件发生:既往及持续存在的风险。
Pediatr Blood Cancer. 2025 Jul;72(7):e31722. doi: 10.1002/pbc.31722. Epub 2025 Apr 22.
3

本文引用的文献

1
Transcranial doppler velocities in a large healthy population of African children.大量非洲健康儿童群体的经颅多普勒速度
Heliyon. 2023 Apr 12;9(4):e15419. doi: 10.1016/j.heliyon.2023.e15419. eCollection 2023 Apr.
2
Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment.镰状细胞病患者大脑中动脉条件血流速度:一项多中心研究及积极治疗的证据。
Arch Dis Child. 2023 Jun;108(6):440-444. doi: 10.1136/archdischild-2022-325106. Epub 2023 Feb 3.
3
Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care.
Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks.
尽管在乌干达羟基脲试验中经颅多普勒速度总体有所改善,但小儿镰状细胞贫血患者仍发生卒中:既往及持续风险
medRxiv. 2025 Jan 29:2025.01.28.25320389. doi: 10.1101/2025.01.28.25320389.
撒哈拉以南非洲的镰状细胞病:可转移的预防和护理策略。
Lancet Haematol. 2021 Oct;8(10):e744-e755. doi: 10.1016/S2352-3026(21)00191-5. Epub 2021 Sep 2.
4
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.肯尼亚葡萄糖-6-磷酸脱氢酶缺乏症儿童中肺炎球菌菌血症的风险。
BMC Med. 2020 Jun 15;18(1):148. doi: 10.1186/s12916-020-01604-y.
5
Empowering newborn screening programs in African countries through establishment of an international collaborative effort.通过建立国际合作努力来加强非洲国家的新生儿筛查项目。
J Community Genet. 2020 Jul;11(3):253-268. doi: 10.1007/s12687-020-00463-7. Epub 2020 May 15.
6
Cerebral oxygen metabolism in adults with sickle cell disease.镰状细胞病成人的脑氧代谢。
Am J Hematol. 2020 Apr;95(4):401-412. doi: 10.1002/ajh.25727. Epub 2020 Jan 28.
7
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study.来自多国家DOVE研究的镰状细胞贫血患儿的表型和治疗的地理差异。
J Clin Med. 2019 Nov 17;8(11):2009. doi: 10.3390/jcm8112009.
8
Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.乌干达儿科镰状细胞贫血患者神经和神经认知功能障碍的负担(BRAIN SAFE):一项横断面研究。
BMC Pediatr. 2019 Oct 25;19(1):381. doi: 10.1186/s12887-019-1758-2.
9
Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.羟基脲降低经颅多普勒血流速度并预防首次中风:乌干达无伤害镰状细胞贫血队列研究
Haematologica. 2020 Jun;105(6):e272-e275. doi: 10.3324/haematol.2019.231407. Epub 2019 Oct 24.
10
Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell Disease.坦桑尼亚镰状细胞病儿童的经颅多普勒和磁共振成像。
Stroke. 2019 Jul;50(7):1719-1726. doi: 10.1161/STROKEAHA.118.018920. Epub 2019 Jun 14.